Tilray Medical Publishes Pioneering Research on the Pharmacokinetics of THC and CBD Formulations

Tilray Medical Publishes Pioneering Research on the Pharmacokinetics of THC and CBD Formulations

New Study Provides Insight into the Bioavailability of Medical Cannabis Formulations for Therapeutic Treatment...

Tilray Medical Publishes Pioneering Research on Pharmacokinetics of THC, CBD Formulations - Cannabis News World

The new study provides insight into the bioavailability of medical cannabis formulations for therapeutic treatment.

Oral formulations for cannabidiol: Improved absolute oral bioavailability of biodegradable cannabidiol self-emulsifying drug delivery systems - Pharma Excipients

Abstract Aim This study aimed to fabricate and evaluate three different SEDDS formulations to improve the oral bioavailability of cannabidiol (CBD). CBD has limited oral bioavailability due to its lipophilicity and extensive first-pass metabolism. By using different emulsifiers in the SEDDS formulations, this study seeks to optimize CBD loading capacities and enhance overall in vivo pharmacokinetic (PK) performance of CBD when administered oral…

Tilray Publishes Pioneering Research on the Pharmacokinetics of THC and CBD Formulations

The Marijuana Herald - Marijuana news and information Tilray Medical, a division of Tilray Brands, Inc., today announced the publication of a study that focuses on comparing the bioavailability of different cannabinoid formulations, “taking a step forward in our understanding of medical cannabis.” The study aimed to assess the pharmacokinetic parameters and relative bioavailability of two D9-tetrahydrocannabinol: cannabidiol (THC:CBD) formulatio…

Tilray Medical Publishes Pioneering Research on Pharmacokinetics of THC, CBD Formulations

The new study provides insight into the bioavailability of medical cannabis formulations for therapeutic treatment.